3D Bioprinting Market Expected to Grow at a CAGR of 18.2% during 2021-2026, Says Stratview Research.

The global 3D bioprinting market is estimated to grow from USD 1.4 billion in 2020 to USD 3.8 billion by 2026, progressing at a CAGR of 18.2% during the forecast period, according to Stratview Research. This exclusive report analyzes the present scenario and forecasts related to the global 3D Bioprinting market.

For more information about this report, visit 3D Bioprinting Market Outlook.

What is 3D Bioprinting?

3D Bioprinting is an additive manufacturing process that uses cells and biomaterials to create biomedical parts that imitate natural tissue characteristics. This printing utilizes the layer-by-layer method to deposit materials called bioinks, to create tissue-like structures later used in the medical engineering field.

Growth Factors

Some key factors augmenting the 3D bioprinting market are: –

• A limited number of organ donors and an increasing senior population with chronic diseases,
• Increasing R&D investment,
• Growing incidence of chronic diseases,
• Rising technological advancement.

Moreover, a surge in public and private funding to support bioprinting research activities further offers immense growth opportunities to the industry players in the coming years.

Click here to get a free sample report.
 

Market Segmentation –

In this report, the market has been bifurcated as follows–

1. By Technology – Inkjet-based, Magnetic Levitation, Syringe-based, Laser-based, Others.
2. By Component – 3D Bioprinters, Biomaterials, Scaffolds.
3. By Application –

• Medical – Tissue and Organ generation, Medical Pills, Prosthetics, and implants.
• Dental,
• Biosensors,
• Consumer/Personal Product Testing,
• Bioinks

1. Region-wise.

Segment-Wise Analysis:

Technology Trends

Based on technology, the inkjet-based segment held a significant market share in 2020 and is estimated to register a healthy CAGR during the forecast timeline. This is mainly ascribed to its ability of printing complex living organs or tissues on the culture substrates with the help of biomaterials, such as bio-inks, which bolsters the segment growth.

Regional Trends

By region, the North American market accounted for a significant share in 2020 and is expected to grow at a substantial CAGR in the following years. This is mainly attributed to a growing demand for 3D bioprinting as this technology has been reconnoitered for drug testing and organ transplantation.

COVID-19 Impact on 3D Bioprinting Market

The COVID-19 outbreak has positively influenced the 3D bioprinting industry.

The pandemic has turned the lives of people worldwide. It resulted in increasing coronavirus patients across the globe, putting a strain on the healthcare sector with limited hospital staff. Hence, as a reaction to the increasing cases of coronavirus, several 3D bioprinting companies are responding to the crises by offering their respective skills to ease the burden on the supply chain and governments.

Take a look at the Table of Contents of the report, here - https://www.stratviewresearch.com/toc/2070/3D-Bioprinting-Market.html

Key Players

The Key players operating in the 3D bioprinting market are-

• 3D Systems Corporation (US)
• Aspect Biosystems Ltd (Canada)
• GeSIM GmbH (Germany)
• Allevi Inc. (US)
• Cyfuse Biomedical KK (Japan)
• Envision TEC GmbH (Germany)
• Organovo Holdings Inc. (US)
• RegenHU SA (Switzerland)
• Stratasys Ltd (US)
• REGEMAT 3D (Spain)

Critical Questions Answered in the Report

• What are the key trends in the 3D bioprinting market?
• How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
• What is the impact of COVID-19 on the 3D bioprinting market?
• What are the key strategies adopted by the major vendors to lead in the 3D bioprinting market?
• What is the market share of the top vendors?
   

Wish to know more about the study? Register Here.

Related Reports –

• Medical Speciality Tubes Market Size, Forecast, and Trends
• Ultrasound Simulator Market

About us –

Stratview Research is a global market research firm that offers reliable market reports, market entry strategies, strategic growth consulting, and more. Our market experts compile high-quality market information to help users obtain granular level clarity on current business trends and expected future developments. Stratview Research also offers customization of the reports. Reach out to our analysts to customize the given report according to your priority/requirement.

Stratview Research has also launched 'Composights', an online portal that offers free thought leadership reports, whitepapers, market report synopsis, and much more for Composites and allied industries, worth US$ 20,000 every year.

Click here to sign up (No costs involved): https://www.stratviewresearch.com/composights/sign-in